
Buy PTD-DBM Research Peptide
Supplied as a lyophilised powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis. A batch-specific Certificate of Analysis is included with every order.

Buy PTD-DBM Research Peptide
Supplied as a lyophilised powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis. A batch-specific Certificate of Analysis is included with every order.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Included
Every batch
Ships Next Day
Order before midnight. Dispatched tomorrow with cold-chain packaging
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Included
Every batch
Ships Next Day
Order before midnight. Dispatched tomorrow with cold-chain packaging
PTD-DBM (Protein Transduction Domain – Dishevelled Binding Motif) is a synthetic chimeric cell-penetrating peptide with a molecular weight of 3082.64 g/mol. Its structure consists of a cell-penetrating protein transduction domain (PTD) fused to a Dishevelled (Dvl) binding motif derived from CXXC5, an intracellular negative-feedback regulator of the Wnt/β-catenin signalling pathway. The PTD component enables the peptide to traverse cell membranes without requiring receptor-mediated endocytosis, while the Dvl-binding motif provides the functional interaction domain that competes with endogenous CXXC5 for binding to Dishevelled. Produced via solid-phase peptide synthesis, PTD-DBM is associated with Wnt/β-catenin pathway modulation.PTD-DBM has been investigated as a tool compound for releasing the CXXC5-mediated negative-feedback brake on Wnt/β-catenin signalling. CXXC5 acts as a negative-feedback regulator of the Wnt/β-catenin pathway by binding to the Dishevelled protein, and PTD-DBM was designed to disrupt this CXXC5–Dishevelled interaction, thereby de-repressing pathway activity. Published studies have documented that PTD-DBM competitively blocks the CXXC5–Dishevelled interaction, stabilising β-catenin and activating Wnt/β-catenin target-gene signalling, and that topical application of the peptide accelerated cutaneous wound healing [1]. Further in vivo work has documented that disrupting the CXXC5–Dishevelled interaction with the competitor peptide activated the Wnt/β-catenin pathway and accelerated hair regrowth and wound-induced hair follicle neogenesis in mouse models, with co-administration of the GSK-3β inhibitor valproic acid further increasing the hair-regrowth response [2], making PTD-DBM a reference compound in preclinical research examining CXXC5–Dishevelled-directed activation of Wnt/β-catenin signalling in skin wound-healing and hair-follicle regeneration models.PTD-DBM is manufactured in a cGMP compliant, ISO9001 certified laboratory to a guaranteed purity of 98% or above. Every batch is independently tested using HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature controlled, monitored cold storage system. Certificates of Analysis are available on request.Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.
References
Editorial Team

Dr. Martina Rossi, PhD
Scientific Contributor and Reviewer
Reviewed and approved 14 June 2026
What Researchers Say
Sign in to leave a reviewNo reviews yet. Be the first to share your research experience.
Frequently Asked Questions
Select Size
Buy 5+ vials to unlock discounts
Quality Guaranteed
Every batch is HPLC-tested to ≥99% purity. Certificate of Analysis and MSDS available with every order.
